The Management of COPD and Co-morbidities in a Post-COVID Environment

Patients with respiratory diseases, including asthma and COPD are known to have co-morbidities resulting in disease management complexity. In a world endemic with the SARS-CoV-2 virus, this has added to the complexity with patients having limited access to routine care and the suspension of routine spirometry.

Taking these into account, how should COPD patients be managed in a post-COVID environment in both primary and secondary care? In this webinar, we have invited renowned Professor Hurst to discuss the impact of COVID-19 on patients’ COPD diagnosis and management, as well as challenges associated with co-morbidities.

We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.

• Professor John Hurst

  Professor of Respiratory Medicine

  Read biography
  Professor John Hurst

  Professor of Respiratory Medicine University College London

  Role and Location

  Professor John Hurst is Professor of Respiratory Medicine at University College London where he has worked since 2007.

  Education

  University of Edinburgh and University of London

  Research Interests

  He has a particular interest in mechanisms and mitigation of exacerbation susceptibility in COPD. His clinical work at Royal Free London NHS Foundation Trust focuses on community and specialist COPD services. He is Senior Clinical Lead to the UK Royal College of Physicians National Asthma and COPD Audit Programme. 

  Memberships

  Professor Hurst is a member of ATS, BTS, ERS, and RCP.